six flags discovery kingdom bring a friend free days

Getting insurers to cover new contraceptives can be difficult, an issue thrust into the spotlight after the Supreme Court overturned Roe v. “It’s just frustrating.” Whitney isn’t alone in her frustration. “If I had had the birth control that I wanted, I wouldn’t have been in this situation,” she said. It can be difficult to remember to ingest the pill every day, which once forced her to take Plan B, also known as the “morning-after pill.” Whitney, who asked that her last name be withheld for privacy reasons, ended up on a birth control pill. “I kind of just gave in and just took what they were offering me,” said Whitney, who is 34 years old and lives in Wisconsin. Her options? Switch contraceptives and risk grueling side effects, or embark on a lengthy appeal process. After changing jobs, her insurance plan denied coverage. In 2020, she finally found an option she liked: a new vaginal ring called Annovera developed by TherapeuticsMD.

Another IUD would prevent pregnancy for too long and she needed an alternative until she was ready for children. “Removing the prescription requirement for a progestin-only birth control pill will be a historic advancement for pregnancy prevention and a remarkable achievement in community public health.”įor Whitney, the desire to eventually have kids sparked a search for a new type of birth control. “For many, a birth control pill may be the best option for them but requiring a prescription is an unnecessary obstacle that can put it out of reach,” commented obstetrician-gynaecologist, Melissa Kottke. HRA Pharma says that nearly a third of adult women in the US who have tried to obtain a prescription for birth control or a refill have reported difficulties doing so. It also comes as President Joe Biden has moved to expand access to birth control in the wake of Roe v Wade, signing an executive order that asks the Department of Health and Human Services (HHS) to expand access to reproductive health services including intrauterine devices, birth control pills, and emergency contraception. The application has been in the works for several year, Welgryn told the New York Times, so the timing is “a bit coincidental.” HRA Pharma is anticipating that the FDA will hold an advisory committee meeting to discuss the Opill switch, and thinks it may be able to get approval in the first half of next year if all goes to plan. The two-drug mifepristone/misoprostol regimen, which has become the most common way to end pregnancies in the US since the start of the pandemic, is now firmly in their sights. “Moving a safe and effective prescription birth control pill to OTC will help even more women and people access contraception without facing unnecessary barriers.”Īccess to birth control is more important than ever after Roe v Wade was struck down, amid reports that anti-abortion campaigners in the US is now turning its attention elsewhere.

“More than 60 years ago, prescription birth control pills in the US empowered women to plan if and when they want to get pregnant,” she added. The company’s chief strategic operations and innovation officer – Frédérique Welgryn – said that the application “marks a ground-breaking moment in contraceptive access and reproductive equity in the US”, where there are around 3 million unintended pregnancies every year. HR Pharma has filed for a prescription to OTC switch for Opill, a decades-old daily progestin-only pill, just a few weeks after its $2 billion takeover by Ireland headquartered Perrigo completed. The move comes as access to birth control becomes a pivotal issue following the landmark ruling by the Supreme Court last month to strip US women of their constitutional protection for the right to abortion, although the company says that the timing is a coincidence. Perrigo’s HRA Pharma subsidiary has become the first drugmaker in the US to seek approval for an over-the-counter contraceptive pill.

Six flags discovery kingdom bring a friend free days